Robert Apple

Track

Insider profile

Currently holds a position at Antares Pharma Inc

Positions

Position Company Period
President, Chief Executive Officer, Director Antares Pharma Inc March 4, 2016 -
President, Chief Executive Officer Antares Pharma Inc Jan. 24, 2016 - March 4, 2016
Chief Operating Officer, Executive Vice President, President - Parenteral Products Division Antares Pharma Inc Nov. 17, 2014 - Jan. 24, 2016
Chief Financial Officer, Chief Operating Officer, Executive Vice President, President - Parenteral Products Division Antares Pharma Inc Sept. 15, 2014 - Nov. 17, 2014
Chief Financial Officer, Executive Vice President, President - Parenteral Products Division Antares Pharma Inc July 8, 2009 - Sept. 15, 2014
Robert Apple's trades of Antares Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
442.56
Quantity 609 +31.9%
Value US$4,339,532
Transaction date
Planned sale
Price
381.23
Quantity 43,836 +35.0%
Value US$2,158,333
Transaction date
Planned sale
Price
241.44
Quantity 48,277 +42.5%
Value US$2,961,728
Transaction date
Planned sale
Price
4.75
Quantity 5,519 -0.2%
Value US$26,215
Transaction date
Planned sale
Price
4.75
Quantity 7,278 -0.3%
Value US$34,570
Transaction date
Planned sale
Price
4.75
Quantity 49,129 -2.1%
Value US$233,363
Transaction date
Planned sale
Price
4.75
Quantity 33,574 -1.4%
Value US$159,476
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-02-19 2021-02-18
PlS Planned sale
609 +31.9%
442.56
US$4,339,532 		609 +31.9% 442.56 US$4,339,532
2021-02-19 2021-02-18
PlS Planned sale
43,836 +35.0%
381.23
US$2,158,333 		43,836 +35.0% 381.23 US$2,158,333
2021-02-19 2021-02-18
PlS Planned sale
48,277 +42.5%
241.44
US$2,961,728 		48,277 +42.5% 241.44 US$2,961,728
2021-02-19 2021-02-17
PlS Planned sale
5,519 -0.2%
4.75
US$26,215 		5,519 -0.2% 4.75 US$26,215
2021-02-10 2021-02-10
PlS Planned sale
7,278 -0.3%
4.75
US$34,570 		7,278 -0.3% 4.75 US$34,570
2021-02-10 2021-02-09
PlS Planned sale
49,129 -2.1%
4.75
US$233,363 		49,129 -2.1% 4.75 US$233,363
2021-02-10 2021-02-08
PlS Planned sale
33,574 -1.4%
4.75
US$159,476 		33,574 -1.4% 4.75 US$159,476